Actively Recruiting
Genomic and Non-Genomic Factors Associated With Breast Cancer Risk Factors and Outcomes in a Diverse South Florida Population
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-02-06
800
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are examining why people have different risks and outcomes for breast cancer and related breast diseases. This observational study focuses on a diverse population in South Florida, aiming to better understand both genomic and non-genomic factors that affect breast cancer risk and outcomes. The study is led by Memorial Sloan Kettering Cancer Center and includes men and women aged 18 years and older who visit breast radiology clinics for biopsy or as new breast patients. Participants will undergo blood collection at the start and during surgery when applicable, as well as tissue collection during surgery if possible. They will also complete surveys at baseline, after surgery, and at 1, 3, and 5 years of follow-up. The study involves participants with BIRADS scores from 0 to 5 and follows their clinical characteristics over up to five years. Throughout the study, participants will provide clinical information through surveys and biological samples to help researchers track their health outcomes. The main outcome measured is the clinical characteristics of participants obtained via surveys over five years. The study provides long-term monitoring of participants' breast health, with no intervention treatments involved, and aims to collect comprehensive data to understand breast cancer risks better.
CONDITIONS
Brief Title
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with BIRADS 0-5, seen in breast radiology clinic at University of Miami, Sylvester Comprehensive Cancer Center, or Jackson Health Systems for biopsy
- Any new breast patient seen at these clinics will be invited to participate
- Men and women 18 years of age and older are eligible to participate
You will not qualify if you...
- Patients younger than 18 years are not eligible
- Patients unable to complete the study surveys are not eligible
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery or biopsy
Participants undergo tissue and blood collection at the time of surgery or biopsy.
1 visit (in-person)
Duration - Up to 5 years
Participants complete surveys at baseline, post-surgery, and at 1, 3, and 5 year follow-up visits to monitor clinical characteristics and outcomes.
5 visits (in-person or remote)
Trial Site Locations
Total: 3 locations
1
University of California, Los Angeles (Specimen Analysis only)
Los Angeles, California, United States, 90095
Not Yet Recruiting
2
University of Miami (Data Collection Only)
Miami, Florida, United States, 33136
Actively Recruiting
3
Memorial Sloan Kettering Cancer Center (All protocol activites)
New York, New York, United States, 10065
Actively Recruiting
Research Team
N
Neha Goel, MD, MPH
G
George Plitas, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here